Q2/2009: Merck Revenues Remain Steady at € 1.9 Billion
- Details
- Category: Merck Group
![Merck KGaA Merck KGaA](http://www.worldpharmanews.com/images/stories/logo/merck_kgaa.gif)
The US Food and Drug Administration (FDA) has approved Tekturna HCT®
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Genzyme Delivers Solid Second-Quarter Financial Results
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Nycomed announces FDA filing for Daxas® in COPD
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Novartis delivers strong operational performance in the first half of 2009
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
- Pharmaceuticals an industry growth leader: Net sales up 12% (local currencies) in first half of 2009 on contributions from new products and expansion in all regions
- R&D maintains momentum: Anti-cancer therapy Afinitor introduced in the US, awaiting EU approval; new biologic Ilaris and OTC brand Prevacid 24HR gain US approvals; clinical trials set to start in July for A(H1N1) pandemic flu vaccine
- H1 2009 operating results advance well, but impacted negatively by currencies:
More Pharma News ...
- Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
- Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease
- GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa
- Abbott and GSK to Collaborate on Molecular Diagnostic Test
- Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effientâ¢
- Bayer acquires exclusive rights to Bioton's insulin SciLin®
- Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial